James Huang - Net Worth and Insider Trading

James Huang Net Worth

The estimated net worth of James Huang is at least $2 Million dollars as of 2024-11-13. James Huang is the Director of CASI Pharmaceuticals Inc and owns about 371,708 shares of CASI Pharmaceuticals Inc (CASI) stock worth over $2 Million. James Huang is the Director of Alaunos Therapeutics Inc and owns about 722 shares of Alaunos Therapeutics Inc (TCRT) stock worth over $1,762. James Huang is also the Director of Windtree Therapeutics Inc and owns about 2,920 shares of Windtree Therapeutics Inc (WINT) stock worth over $1,638. Details can be seen in James Huang's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Huang has not made any transactions after 2022-09-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James Huang

To

James Huang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Huang owns 4 companies in total, including Alaunos Therapeutics Inc (TCRT) , CASI Pharmaceuticals Inc (CASI) , and Windtree Therapeutics Inc (WINT) among others .

Click here to see the complete history of James Huang’s form 4 insider trades.

Insider Ownership Summary of James Huang

Ticker Comapny Transaction Date Type of Owner
TCRT Alaunos Therapeutics Inc 2022-06-22 director
CASI CASI Pharmaceuticals Inc 2022-09-08 director
WINT Windtree Therapeutics Inc 2023-02-22 director
LIMIT LIMIT 2021-05-12 director & Chief Executive Officer

James Huang Latest Holdings Summary

James Huang currently owns a total of 3 stocks. Among these stocks, James Huang owns 371,708 shares of CASI Pharmaceuticals Inc (CASI) as of September 8, 2022, with a value of $2 Million and a weighting of 99.84%. James Huang owns 722 shares of Alaunos Therapeutics Inc (TCRT) as of September 1, 2021, with a value of $1,762 and a weighting of 0.08%. James Huang also owns 2,920 shares of Windtree Therapeutics Inc (WINT) as of October 19, 2021, with a value of $1,638 and a weighting of 0.08%.

Latest Holdings of James Huang

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CASI CASI Pharmaceuticals Inc 2022-09-08 371,708 5.60 2,081,565
TCRT Alaunos Therapeutics Inc 2021-09-01 722 2.44 1,762
WINT Windtree Therapeutics Inc 2021-10-19 2,920 0.56 1,638

Holding Weightings of James Huang


James Huang Form 4 Trading Tracker

According to the SEC Form 4 filings, James Huang has made a total of 4 transactions in CASI Pharmaceuticals Inc (CASI) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in CASI Pharmaceuticals Inc is the acquisition of 55,573 shares on September 8, 2022, which cost James Huang around $229,516.

According to the SEC Form 4 filings, James Huang has made a total of 1 transactions in Alaunos Therapeutics Inc (TCRT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Alaunos Therapeutics Inc is the acquisition of 667 shares on September 1, 2021, which cost James Huang around $171,000.

According to the SEC Form 4 filings, James Huang has made a total of 11 transactions in Windtree Therapeutics Inc (WINT) over the past 5 years, including 11 buys and 0 sells. The most-recent trade in Windtree Therapeutics Inc is the acquisition of 56 shares on October 19, 2021, which cost James Huang around $95,000.

Insider Trading History of James Huang

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James Huang Trading Performance

GuruFocus tracks the stock performance after each of James Huang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Huang is -25.74%. GuruFocus also compares James Huang's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Huang within 3 months outperforms 1 times out of 16 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James Huang's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James Huang

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 16 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.92 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -7.1 LIMIT LIMIT LIMIT LIMIT LIMIT

James Huang Ownership Network

Ownership Network List of James Huang

No Data

Ownership Network Relation of James Huang

Insider Network Chart

James Huang Owned Company Details

What does Alaunos Therapeutics Inc do?

Who are the key executives at Alaunos Therapeutics Inc?

James Huang is the director of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .

Alaunos Therapeutics Inc (TCRT) Insider Trades Summary

Over the past 18 months, James Huang made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net sale of 68,014 shares made by Boyle Kevin S. Sr. ,

In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 453 shares of Alaunos Therapeutics Inc (TCRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 453 shares.

Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alaunos Therapeutics Inc Insider Transactions

No Available Data

James Huang Mailing Address

Above is the net worth, insider trading, and ownership report for James Huang. You might contact James Huang via mailing address: 9620 Medical Center Drive, Suite 300, Rockville Md 20850.